Avra Medical (OTC: AVMR) Fully autonomous robotic surgery technology

Barry Cohen, CEO, Avra Medical
Barry Cohen, CEO, Avra Medical

 

 

Discover Tomorrow’s Winning Stocks!
Get our latest stock reports before everyone else! Actionable news, and breakout stocks w multi-bagger upside potential — delivered directly to your inbox.
Your privacy is our priority. Your email address will never be sold or shared with anyone else.

 

 

 

 

 

Avra Medical (OTC: AVMR) interview with Barry Cohen, CEO. Barry discusses the technology Avra is developing for fully autonomous robotic surgery. The company’s goal is to receive FDA approval and enter commercialization by 2020, with an initial focus on automated dermatological surgery procedures.